Literature DB >> 19258835

Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative.

Charles V Pollack1, Judd E Hollander, Anita Y Chen, Eric D Peterson, Sripal Bangalore, Frank W Peacock, Christopher P Cannon, John G Canto, Brian W Gibler, Magnus E Ohman, Matthew T Roe.   

Abstract

Evidence-based guidelines call for advanced and definitive therapy for patients with non-ST-elevation myocardial infarction (NSTEMI). It is not known whether these guidelines are follow more diligently when patients arrive in the ED during regular hours, during which hospital resources including cardiology consultation may be more readily available. To determine whether patients with NSTEMI who present to the ED outside of usual hours have prolonged times to advanced and definitive therapy and poorer short-term outcomes.We examined NSTEMI patients from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) national quality improvement initiative (January 2001-April 2003) and compared demographics, risk profiles, intensity of medical management, and timing and intensity of intervention by whether presentation occurred during usual or off hours. We analyzed 34,297 NSTEMI presentations; 15,090 (44%) occurred during usual hours; 19,207 (56%) occurred during off hours. Off-hours-presenting patients had generally higher cardiac risk and received initial ECGs more quickly than patients who presented during usual hours (median 15 minutes vs. 18 minutes, P < 0.0001), and received similar (although suboptimal) medical management. In contrast, those who presented during off hours were less likely to receive timely diagnostic angiography, PCI, and bypass surgery (cath: median 32.9 hours vs. 24.3 hours, P < 0.0001; PCI: 28.6 hours vs. 23.6 hours, P < 0.0001). Despite these differences, in-hospital outcomes were similar. Time of patient presentation has a modest impact on the timeliness of intervention in NSTEMI but was not associated with lower mortality. Although intensity of medical management was similar between groups, it was generally lower than current guidelines recommend, indicating potential for improvement in NSTEMI outcomes, regardless of time of presentation.

Entities:  

Mesh:

Year:  2009        PMID: 19258835     DOI: 10.1097/HPC.0b013e3181980f9f

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  6 in total

1.  Anti-glioma action of aloe emodin: the role of ERK inhibition.

Authors:  S Mijatovic; D Maksimovic-Ivanic; J Radovic; Dj Miljkovic; Lj Harhaji; O Vuckovic; S Stosic-Grujicic; M Mostarica Stojkovic; V Trajkovic
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

2.  On- versus off-hour care for patients with non-ST-segment elevation myocardial infarction in Germany : Exemplary results within the chest pain unit concept.

Authors:  F Breuckmann; F Remberg; D Böse; J Waltenberger; D Fischer; T Rassaf
Journal:  Herz       Date:  2016-05-19       Impact factor: 1.443

3.  Is there an association between time of admission and in-hospital mortality in patients with non-ST-elevation myocardial infarction? A meta-analysis.

Authors:  Xiantao Wang; Jie Yan; Qiang Su; Yuhan Sun; Huafeng Yang; Lang Li
Journal:  Sci Rep       Date:  2015-09-22       Impact factor: 4.379

Review 4.  Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis.

Authors:  Atsushi Sorita; Adil Ahmed; Stephanie R Starr; Kristine M Thompson; Darcy A Reed; Larry Prokop; Nilay D Shah; M Hassan Murad; Henry H Ting
Journal:  BMJ       Date:  2014-01-21

5.  Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.

Authors:  Lior Lupu; Louay Taha; Ariel Banai; Hezzy Shmueli; Ariel Borohovitz; Shlomi Matetzky; Mustafa Gabarin; Mony Shuvy; Roy Beigel; Katia Orvin; Sa'ar Minha; Yacov Shacham; Shmuel Banai; Michael Glikson; Elad Asher
Journal:  Clin Cardiol       Date:  2022-03-09       Impact factor: 3.287

6.  Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.

Authors:  Xia Han; Lili Liu; Jiamin Niu; Jun Yang; Zengtang Zhang; Zhiqiang Zhang
Journal:  Med Sci Monit       Date:  2015-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.